
               
               
               CLINICAL PHARMACOLOGY
               
                  Corticoids suppress the inflammatory response to a variety of agents and they may delay healing. Since corticoids may inhibit the body's defense mechanism against infection, a concomitant antimicrobial drug may be used when this inhibition is considered to be clinically significant in a particular case.
                  The anti-infective components in the combination are included to provide action against specific organisms susceptible to them. Polymyxin B sulfate, bacitracin zinc, and neomycin sulfate together are considered active against the following microorganisms: Staphylococcus aureus, streptococci, including Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae, Klebsiella-Enterobacter species, Neisseria  species, and Pseudomonas aeruginosa.
                  The product does not provide adequate coverage against Serratia marcescens.
                  The relative potency of corticosteroids depends on the molecular structure, concentration, and release from the vehicle.
               
               
            
         